Drug halts organ damage in inflammatory genetic disorder, study suggests

A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease. This rare and debilitating genetic disorder causes persistent inflammation and ongoing tissue damage.

Read the whole article on Science Daily

More from Science Daily